SCHEMBL3608753

SCHEMBL3608753

CCCCC(O)c1c(C)nn(C)c1Oc1cc(OCc2ccc(OC)cc2)c(Cl)cc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
CRHBP P24387 1/20 0.37
HTT P42858 1/20 0.37
CRHR2 Q13324 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
CNR1 P21554 1/20 0.34
ACHE P22303 1/20 0.34
CNR2 P34972 1/20 0.34
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3604177 0.87 ALDH1A1 (0.38) ALDH1A1KMT2AKDM4ECYP1A2CYP2C9
SCHEMBL3613887 0.85 CYP1A2 (0.42) ALDH1A1KMT2AMAPTSMN1; SMN2KDM4E
SCHEMBL3612556 0.83 ALDH1A1 (0.37) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL3604681 0.82 SMN1; SMN2 (0.40) ALDH1A1KMT2AMEN1MAPTCRHBP
SCHEMBL3615309 0.81 CYP19A1 (0.36) ALDH1A1KMT2AMAPTHTTKDM4E
SCHEMBL3597738 0.81 ALDH1A1 (0.40) ALDH1A1KMT2ASMN1; SMN2KDM4ECYP1A2
SCHEMBL3612786 0.80 ALDH1A1 (0.39) ALDH1A1KMT2ASMN1; SMN2KDM4ECYP1A2
SCHEMBL3615067 0.79 ALDH1A1 (0.38) ALDH1A1KMT2ASMN1; SMN2KDM4ECYP1A2
SCHEMBL3613236 0.79 KDM4E (0.54) ALDH1A1KMT2AMAPTSMN1; SMN2KDM4E
SCHEMBL3604425 0.79 KDM4E (0.43) ALDH1A1KMT2AMAPTKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016396-A1 PYRAZOLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-01-21 US disclosed
EP-2128138-A1 PYRAZOLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016396-A1 PYRAZOLE COMPOUND SLC5A1, SLC5A2, GLP1R ALDH1A1 365/4885KMT2A 2269/4885MEN1 2280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.